Tag:
Catalent Pharma Solutions
Latest Headlines
Latest Headlines
Download our eBook 'Supplying global clinical trials: Keys to avoiding costly delays'
Getting clinical trials right, and right the first time, is crucial for biopharma companies, especially as the cost of getting a drug to market is skyrocketing. Matthew Herper estimates in "The...
Report: Catalent wants $400M loan to back Aptuit unit buyout
Catalent Pharma Solutions aims to raise $400 million in term loan financing to support the company's buyout of Aptuit's clinical trial supplies business, Bloomberg reported, citing an unnamed...
Catalent snaps up Aptuit's trial supplies ops for $410M
Pumping up its clinical trial services muscle, Catalent Pharma announced it is buying Aptuit's clinical trial supply business for $410 million in cash. Aptuit, a contract research and manufacturing
